MYH9 and breast cancer: TMEM120B accelerated the cycling of β1-integrin and the assembling of FAs by activating the TAZ-mTOR signaling axis via binding to MYH9 through its coil-coil domain, thus strengthening proliferation and invasion, maintaining the stemness of breast cancer cells, and promoting chemoresistance.